Abstract
We have investigated the association of the recently identified IL6R polymorphisms with the serum levels of soluble IL-6 receptor (sIL-6R). sIL-6R is generated by shedding of the membrane-bound receptor (IL-6Rα) or alternative mRNA splicing. In total, 115 healthy volunteers were genotyped, with 70 of them analyzed for sIL-6R levels. Using the PCR/RFLP methods, two important polymorphic sites were selected for genotyping: the 48892A/C (D358A) in exon 9 and the −183G/A in the promoter region. In exon 9, C allele carriers had higher sIL-6R level (P<0.0001) showing that this sequence variation, which corresponds to the proteolytic cleavage site of IL-6Rα, strongly influences the serum sIL-6R levels. In the promoter region, G allele carriers had lower sIL-6R levels (P<0.0082) compared with the A allele carriers. This could be attributed to the linkage disequilibrium (D′=0.54, χ2=51.3, P<0.0001) between the −183G/A and the 48892A/C gene polymorphisms.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 6 digital issues and online access to articles
$119.00 per year
only $19.83 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Yamasaki K, Taga T, Hirata Y . Cloning and expression of the human Interleukin-6 (BSF-2/IFN-beta) receptor. Science 1988; 241: 825–828.
Szpirer J, Szpirer C, Riviere M et al. The interleukin-6-dependent DNA-binding protein gene (transcription factor 5: TCF5) maps to human chromosome 20 and rat chromosome 3, the IL-6 receptor locus (IL-6R) to human chromosome 1 and the rat chromosome 2, and the rat IL-6 gene to rat chromosome 4. Genomics 1991; 10: 539–546.
Snyder L, Renauld JC, Szpirer C, Content J . Cloning and chromosal localization of a pseudogene corresponding to an mRNA for a soluble IL-6R. DNA Seq 1995; 5: 311–314.
Müllberg J, Schooltnik H, Stoyan T et al. The soluble human interleukin-6 receptor is generated by shedding. Eur J Immunol 1993; 23: 473–480.
Horiuchi S, Ampofo W, Koyanagi Y et al. High-level production of alternatively spliced soluble interleukin-6 receptor in serum of patients with adult T-cell leukaemia/HTLV-I-associated myelopathy. Immunology 1998; 95: 360–369.
Lust J, Donovan K, Kline M, Greipp P, Kyle R, Maihle N . Isolation of an mRNA encoding a soluble form of the human interleukin-6 receptor. Cytokine 1992; 4: 96–100.
Müllberg J, Oberthür W, Lottspeich F et al. The soluble human IL-6 receptor—mutational characterization of the proteolytic cleavage site. J Immunol 1994; 15: 4958–4968.
Walev I, Vollmer P, Palmer M, Bhakdi S, Rose-John S . Pore-forming toxins trigger shedding of receptors for interleukin 6 and lipopolysaccharide. Proc Natl Acad Sci USA 1996; 93: 7882–7887.
Modur V, Li Y, Zimmerman GA, Prescott SM, McIntyre TM . Retrograde inflammatory signaling from neutrophils to endothelial cells by soluble interleukin-6 alpha. J Clin Invest 1997; 100: 2752–2756.
Peters M, Schirmacher P, Goldschmitt J et al. Extramedullary expansion of hematopoietic progenitor cells in IL-6/sIL-6R double transgenic mice. J Exp Med 1997; 185: 755–766.
Romano M, Sironi M, Toniatti C et al. Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment. Immunity 1997; 6: 315–325.
Tajima S, Tsuji K, Ebihara Y et al. Analysis of interleukin-6 receptor and gp130 expressions and proliferative capability of human CD34+ cells. J Exp Med 1996; 184: 1357–1364.
Gaillard JP, Liautard J, Klein B, Brochier J . Major role of the interleukin-6/interleukin-6 receptor complex for the proliferation of interleukin-6-dependent human myeloma cell lines. Eur J Immunol 1997; 27: 3332–3340.
Mitsuyama K, Toyonaga A, Sasaki E et al. Soluble interleukin-6 receptors in inflammatory bowel disease: relation to circulating interleukin-6. Gut 1995; 36: 45–49.
Lavabre-Bertrand T, Exbrayar C, Lautard J et al. Detection of membrane and soluble interleukin-6 receptor in lymphoid malignancies. Br J Haematol 1995; 91: 871–877.
Hossaim F, Devogelaer J, van Damme J, Deuxchaines C, van Snick J . Interleukin-6 in synovial fluid and serum in patients with rheumatoid arthritis and other inflammatory arthritis. Art Rheum 1988; 31: 784–788.
Pietruska M, Pietruski J, Stokowska W, Jablonska E . Interleukin-6 and its soluble receptor in periodontitis. Arch Immun Therap Exp 1998; 46: 305–309.
Kim HL, Lee HS, Kim YJ et al. Identification of novel SNPs in the Interleukin 6 Receptor Gene. Hum Mutat 2003; 21: 450–451.
Chua S, Chung N, Wu-Peng S et al. Phenotypes of mouse diabetes and rat fatty due to mutations in the OB (leptin) receptor. Science 1996; 271: 994–996.
Lahlou N, Clement K, Carel JC et al. Soluble leptin receptor in serum of subjects with complete resistance to leptin. Relation to fat mass. Diabetes 2000; 49: 1347–1352.
Gronostajski R . Roles of the NFI/CTF gene family in transcription and development. Gene 2000; 249: 31–45.
Acknowledgements
We are grateful to Drs Emire Gou and Ikuyo Ikezawa (Division of Periodontology, Niigata University) for their technical assistance and for the collection of samples.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Galicia, J., Tai, H., Komatsu, Y. et al. Polymorphisms in the IL-6 receptor (IL-6R) gene: strong evidence that serum levels of soluble IL-6R are genetically influenced. Genes Immun 5, 513–516 (2004). https://doi.org/10.1038/sj.gene.6364120
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.gene.6364120
Keywords
This article is cited by
-
Association of Interleukin 6 and Interleukin 8 genes polymorphisms with house dust mite-induced nasal-bronchial allergy in a sample of Indian patients
Egyptian Journal of Medical Human Genetics (2022)
-
Soluble IL-6R-mediated IL-6 trans-signaling activation contributes to the pathological development of psoriasis
Journal of Molecular Medicine (2021)
-
Cathepsin S provokes interleukin-6 (IL-6) trans-signaling through cleavage of the IL-6 receptor in vitro
Scientific Reports (2020)
-
Activation of Toll-like Receptor 2 (TLR2) induces Interleukin-6 trans-signaling
Scientific Reports (2019)
-
From physiology to disease and targeted therapy: interleukin-6 in inflammation and inflammation-associated carcinogenesis
Archives of Toxicology (2015)